Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications

키워드

참고문헌 (73)

1. Kumarasamy KK, "Emergence of a new antibiotic resistance mechanismin India, Pakistan, and the UK: a molecular, biological,and epidemiological study", Lancet Infect Dis, 10, pp.597~602 (2010)
2. Jean SS, "High burden of antimicrobial resistancein Asia", Int J Antimicrob Agents, 37, pp.291~295 (2011)
3. Nickerson EK, "Staphylococcusaureus disease and drug resistance in resourcelimitedcountries in south and east Asia", Lancet Infect Dis, 9, pp.130~135 (2009)
4. Kim SH, "ANSORP Study Group. Changing trendsin antimicrobial resistance and serotypes of Streptococcuspneumoniae isolates in Asian countries: an Asian Networkfor Surveillance of Resistant Pathogens (ANSORP) study", Antimicrob Agents Chemother, 56, pp.1418~1426 (2012)
5. Song JH, "High prevalence of antimicrobial resistanceamong clinical Streptococcus pneumoniae isolatesin Asia (an ANSORP study)", Antimicrob Agents Chemother, 48, pp.2101~2107 (2004)
6. Song JH, "Spread of drug-resistantStreptococcus pneumoniae in Asian countries: Asian Networkfor Surveillance of Resistant Pathogens (ANSORP)Study", Clin Infect Dis, 28, pp.1206~1211 (1999)
7. Ho PL, "Emergence of fluoroquinolone resistance among multiplyresistant strains of Streptococcus pneumoniae in HongKong", Antimicrob Agents Chemother, 43, pp.1310~1313 (1999)
8. Ho PL, "Risk factors for acquisition of levofloxacin-resistantStreptococcus pneumoniae: a case-control study", ClinInfect Dis, 32, pp.701~707 (2001)
9. Hsieh YC, "Circulation of international clones of levofloxacin nonsusceptibleStreptococcus pneumoniae in Taiwan", Clin MicrobiolInfect, 16, pp.973~978 (2010)
10. Kang CI, "Bacteremic pneumonia caused by extensivelydrug-resistant Streptococcus pneumoniae", J Clin Microbiol, 50, pp.4175~4177 (2012)
11. Kang CI, "Risk factors and pathogenic significance ofbacteremic pneumonia in adult patients with communityacquiredpneumococcal pneumonia", J Infect, 66, pp.34~40 (2013)
12. Song JH, "Asian Network for Surveillance of ResistantPathogens Study Group. Clinical outcomes of pneumococcalpneumonia caused by antibiotic-resistant strains in asiancountries: a study by the Asian Network for Surveillance ofResistant Pathogens", Clin Infect Dis, 38, pp.1570~1578 (2004)
13. Song JS, "Risk factors for 30-day mortalityin adult patients with pneumococcal bacteraemia, and theimpact of antimicrobial resistance on clinical outcomes", Epidemiol Infect, 140, pp.1267~1276 (2012)
14. Kang CI, "ian Network for Surveillance of ResistantPathogens (ANSORP) Study Group. Association of levofloxacinresistance with mortality in adult patients with invasivepneumococcal diseases: a post hoc analysis of a prospectivecohort", Infection, 41, pp.151~157 (2013)
15. Choi SH, "Impact of penicillin nonsusceptibilityon clinical outcomes of patients with nonmeningeal Streptococcuspneumoniae bacteremia in the era of the 2008clinical and laboratory standards institute penicillin breakpoints", Antimicrob Agents Chemother, 56, pp.4650~4655 (2012)
16. Grundmann H, "Mathematical modelling: a toolfor hospital infection control", Lancet Infect Dis, 6, pp.39~45 (2006)
17. Chung DR, "Asian Network for Surveillance of ResistantPathogens Study Group. High prevalence of multidrugresistantnonfermenters in hospital-acquired pneumonia inAsia", Am J Respir Crit Care Med, 184, pp.1409~1417 (2011)
18. Xie DS, "Ventilatorassociatedpneumonia in intensive care units in HubeiProvince, China: a multicentre prospective cohort survey", JHosp Infect, 78, pp.284~288 (2011)
19. Naimi TS, "Comparison of community-and health care-associated methicillin-resistantStaphylococcus aureus infection", JAMA, 290, pp.2976~2984 (2003)
20. Vandenesch F, "Community-acquired methicillin-resistant Staphylococcusaureus carrying Panton-Valentine leukocidin genes:worldwide emergence", Emerg Infect Dis, 9, pp.978~984 (2003)
21. Song JH, "ANSORP Study Group. Spread of methicillin-resistant Staphylococcus aureus between the communityand the hospitals in Asian countries: an ANSORPstudy", J Antimicrob Chemother, 66, pp.1061~1069 (2011)
22. Ho PL, "HongKong CA-MRSA surveillance network. Community-associatedmethicillin-resistant and methicillin-sensitive Staphylococcusaureus: skin and soft tissue infections in HongKong", Diagn Microbiol Infect Dis, 61, pp.245~250 (2008)
23. Nickerson EK, "Peacock SJ. Emergence of community-associated methicillin-resistant Staphylococcus aureuscarriage in children in Cambodia", Am J Trop Med Hyg, 84, pp.313~317 (2011)
24. Wang JL, "Comparison of both clinical featuresand mortality risk associated with bacteremia due tocommunity-acquired methicillin-resistant Staphylococcusaureus and methicillin-susceptible S. aureus.", Clin Infect Dis, 46, pp.799~806 (2008)
25. Cosgrove SE, "Comparison of mortality associatedwith methicillin-resistant and methicillin-susceptibleStaphylococcus aureus bacteremia: a meta-analysis", ClinInfect Dis, 36, pp.53~59 (2003)
26. Kang CI, "Asian Network for Surveillance of ResistantPathogens (ANSORP) Study Group. Clinical impact ofmethicillin resistance on outcome of patients with Staphylococcusaureus infection: a stratified analysis according tounderlying diseases and sites of infection in a large prospectivecohort", J Infect, 61, pp.299~306 (2010)
27. Nickerson EK, "Staphylococcus aureus bacteraemia in a tropical setting:patient outcome and impact of antibiotic resistance", PLoSOne, 4, pp.e4308~ (2009)
28. Hiramatsu K, "Dissemination in Japanesehospitals of strains of Staphylococcus aureus heterogeneouslyresistant to vancomycin", Lancet, 350, pp.1670~1673 (1997)
29. Ho CM, "Prevalence and accessory gene regulator (agr) analysisof vancomycin-intermediate Staphylococcus aureus amongmethicillin-resistant isolates in Taiwan--SMART program,2003", Eur J Clin Microbiol Infect Dis, 29, pp.383~389 (2010)
30. Song JH, "Asian Network for Surveillanceof Resistant Pathogens Study Group. Emergencein Asian countries of Staphylococcus aureus with reducedsusceptibility to vancomycin", Antimicrob Agents Chemother, 48, pp.4926~4928 (2004)
31. Hsueh PR, "Clonal disseminationof meticillin-resistant and vancomycin-intermediateStaphylococcus aureus in a Taiwanese hospital", IntJ Antimicrob Agents, 36, pp.307~312 (2010)
32. Park KH, "Comparison of the clinicalfeatures, bacterial genotypes and outcomes of patients withbacteraemia due to heteroresistant vancomycin-intermediateStaphylococcus aureus and vancomycin-susceptible S.aureus", J Antimicrob Chemother, 67, pp.1843~1849 (2012)
33. Fong RK, "Clinical features andtreatment outcomes of vancomycin-intermediate Staphylococcusaureus (VISA) and heteroresistant vancomycinintermediateStaphylococcus aureus (hVISA) in a tertiarycare institution in Singapore", Eur J Clin Microbiol Infect Dis, 28, pp.983~987 (2009)
34. 이경원, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
35. 이경원, "Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007", Yonsei Medical Journal, 51(6), pp.901~911 (2010), 연세대학교의과대학
36. Lu CL, "Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan:implication of sequence type for prognosis", J AntimicrobChemother, 67, pp.2243~2249 (2012)
37. Zhao C, "Antimicrobial resistance trends among 5608 clinicalGram-positive isolates in China: results from the Gram-PositiveCocci Resistance Surveillance program (2005-2010)", Diagn Microbiol Infect Dis, 73, pp.174~181 (2012)
38. Yoon YK, "Clinical prediction rule for identifying patientswith vancomycin-resistant enterococci (VRE) at the timeof admission to the intensive care unit in a low VRE prevalencesetting", J Antimicrob Chemother, 67, pp.2963~2969 (2012)
39. Yoon YK, "Risk factors for prolonged carriage of vancomycin resistant Enterococcus faecium among patients in intensivecare units: a case-control study", J Antimicrob Chemother, 66, pp.1831~1838 (2011)
40. DiazGranados CA, "Comparisonof mortality associated with vancomycin-resistantand vancomycin-susceptible enterococcal bloodstreaminfections: a meta-analysis", Clin Infect Dis, 41, pp.327~333 (2005)
41. Vydra J, "Enterococcal bacteremia is associatedwith increased risk of mortality in recipients of allogeneichematopoietic stem cell transplantation", Clin Infect Dis, 55, pp.764~770 (2012)
42. Han SH, "Vancomycin-resistantenterococci bacteremia: risk factors for mortality and influenceof antimicrobial therapy on clinical outcome", J Infect, 58, pp.182~190 (2009)
43. Chow JW, "In vitro susceptibilities of aerobic andfacultative gram-negative bacilli isolated from patients withintra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)", Surg Infect (Larchmt), 6, pp.439~448 (2005)
44. Lu PL, "Epidemiology and antimicrobialsusceptibility profiles of Gram-negative bacteriacausing urinary tract infections in the Asia-Pacific region:2009-2010 results from the Study for Monitoring AntimicrobialResistance Trends (SMART)", Int J Antimicrob Agents, 40, pp.S37~S43 (2012)
45. Hawser SP, "Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli inthe Asia-Pacific region: data from the Study for MonitoringAntimicrobial Resistance Trends (SMART) program, 2007", Antimicrob Agents Chemother, (2009), pp.3280~3284 (2007)
46. Ko KS, "Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceaeisolated in Korean hospitals", Diagn Microbiol InfectDis, 61, pp.453~459 (2008)
47. Jean SS, "Nationwide surveillance of antimicrobialresistance among Enterobacteriaceae in intensive care units in Taiwan", Eur J Clin Microbiol Infect Dis, 28, pp.215~220 (2009)
48. Sung YK, "The clinical epidemiologyand outcomes of bacteremic biliary tract infectionscaused by antimicrobial-resistant pathogens", Am JGastroenterol, 107, pp.473~483 (2012)
49. Park SH, "Molecular epidemiology of extendedspectrumβ-lactamase-producing Escherichia coli in thecommunity and hospital in Korea: emergence of ST131producing CTX-M-15", BMC Infect Dis, 12, pp.149~ (2012)
50. Chung HC, "Bacteremia caused by extendedspectrum-beta-lactamase-producing Escherichia colisequence type ST131 and non-ST131 clones: comparisonof demographic data, clinical features, and mortality", AntimicrobAgents Chemother, 56, pp.618~622 (2012)
51. Cao X, "Molecular characterization and antimicrobialsusceptibility testing of Escherichia coli isolatesfrom patients with urinary tract infections in 20 Chinesehospitals", J Clin Microbiol, 49, pp.2496~2501 (2011)
52. Ho PL, "Escherichia coliO25b-ST131 is an important cause of antimicrobialresistantinfections in women with uncomplicated cystitis", J AntimicrobChemother, 67, pp.2534~2535 (2012)
53. Matsumura Y, "Kyoto-Shiga Clinical MicrobiologyStudy Group. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups amongextended-spectrum-beta-lactamase-producing Escherichiacoli in Japan", J Antimicrob Chemother, 67, pp.2612~2620 (2012)
54. Ho WS, "Prevalence and characterizationof multidrug-resistant and extended-spectrum betalactamase-producing Escherichia coli from pediatric wardsof a Malaysian hospital", Microb Drug Resist, 18, pp.408~416 (2012)
55. Kiratisin P, "Molecularcharacterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiellapneumoniae isolates causing health care-associatedinfection in Thailand, where the CTX-M family is endemic", Antimicrob Agents Chemother, 52, pp.2818~2824 (2008)
56. Schwaber MJ, "Mortality and delay in effectivetherapy associated with extended-spectrum beta-lactamaseproduction in Enterobacteriaceae bacteraemia: a systematicreview and meta-analysis", J Antimicrob Chemother, 60, pp.913~920 (2007)
57. Kang CI, "KoreanNetwork for Study of Infectious Diseases. Risk factors forinfection and treatment outcome of extended-spectrumbeta-lactamase-producing Escherichia coli and Klebsiellapneumoniae bacteremia in patients with hematologic malignancy", Ann Hematol, 91, pp.115~121 (2012)
58. Kim SH, "Escherichia coli and Klebsiellapneumoniae bacteremia in patients with neutropenic fever:factors associated with extended-spectrum β-lactamaseproduction and its impact on outcome", Ann Hematol, 92, pp.533~541 (2013)
59. Kang CI, "Korean Networkfor Study of Infectious Diseases (KONSID). Risk factorsand treatment outcomes of community-onset bacteraemiacaused by extended-spectrum beta-lactamase-producingEscherichia coli", Int J Antimicrob Agents, 36, pp.284~287 (2010)
60. Park SH, "Emergence of extended-spectrum β-lactamaseproducingescherichia coli as a cause of community-onsetbacteremia in South Korea: risk factors and clinical outcomes", Microb Drug Resist, 17, pp.537~544 (2011)
61. Lee JA, "Epidemiology andclinical features of community-onset bacteremia causedby extended-spectrum β-lactamase-producing Klebsiellapneumoniae", Microb Drug Resist, 17, pp.267~273 (2011)
62. Hu B, "Clinicaland economic outcomes associated with communityacquiredintra-abdominal infections caused by extendedspectrum beta-lactamase (ESBL) producing bacteria inChina", Curr Med Res Opin, 26, pp.1443~1449 (2010)
63. Gupta N, "CarbapenemresistantEnterobacteriaceae: epidemiology and prevention", Clin Infect Dis, 53, pp.60~67 (2011)
64. Yang Q, "Phenotypicand genotypic characterization of Enterobacteriaceae withdecreased susceptibility to carbapenems: results from largehospital-based surveillance studies in China", AntimicrobAgents Chemother, 54, pp.573~577 (2010)
65. Nordmann P, "The real threat of Klebsiellapneumoniae carbapenemase-producing bacteria", LancetInfect Dis, 9, pp.228~236 (2009)
66. Jean SS, "Nationwide surveillance of antimicrobialresistance among non-fermentative Gram-negative bacteriain Intensive Care Units in Taiwan: SMART programme data2005", Int J Antimicrob Agents, 33, pp.266~271 (2009)
67. Wang H, "Antimicrobial resistanceamong clinical isolates from the Chinese Meropenem SurveillanceStudy (CMSS), 2003-2008", Int J Antimicrob Agents, 35, pp.227~234 (2010)
68. Kuo SC, "TSAR Hospitals. Emergenceof extensively drug-resistant Acinetobacter baumanniicomplex over 10 years: nationwide data from the TaiwanSurveillance of Antimicrobial Resistance (TSAR) program", BMC Infect Dis, 12, pp.200~ (2012)
69. Kiratisin P, "Comparative in vitro activity of carbapenemsagainst major Gram-negative pathogens: results ofAsia-Pacific surveillance from the COMPACT II study", Int JAntimicrob Agents, 39, pp.311~316 (2012)
70. Liu YM, "In vitro susceptibilitiesof non-Enterobacteriaceae isolates from patients withintra-abdominal infections in the Asia-Pacific region from2003 to 2010: results from the Study for Monitoring AntimicrobialResistance Trends (SMART)", Int J AntimicrobAgents, (40), pp.S11~S17 (2012)
71. Joo EJ, "Risk factors for mortality in patientswith Pseudomonas aeruginosa bacteremia: clinical impactof antimicrobial resistance on outcome", Microb Drug Resist, 17, pp.305~312 (2011)
72. Sheng WH, "A multicenter study of risk factors andoutcome of hospitalized patients with infections due tocarbapenem-resistant Acinetobacter baumannii", Int J InfectDis, 14, pp.e764~e769 (2010)
73. Kwon KT, "Impact of imipenem resistance on mortality in patientswith Acinetobacter bacteraemia", J Antimicrob Chemother, 59, pp.525~530 (2007)

관련 논문AI추천